IRA Istituto Ricerche Applicate is specialized in the production of class I, IIA, IIB and III CE-marked Medical Devices for contract manufacturing, providing cutting-edge and innovative technology in the research & development and productive processes. IRA's strength lies in the production of injectable class III CE0373 marked Medical Devices made of Linear & Crosslinked Hyaluronic Acid, for aesthetic & intra-articular use, which have high levels of purity, low concentration of nucleic and proteins and endotoxin levels 0.5 EU/mL, which is significantly lower than European Pharmacopoeia limits for injectable products. Thus, our Company has specialized in the development of products which comply to the rigorous standards for stability, purity and technique. IRA is also a reknown manufacturer of raw materials for cosmetic use as delivery systems of active ingredients. Certifications: UNI EN ISO 9001:2008, UNI EN ISO 13485:2012, UNI EN ISO 22716:2008, EFfCI GMP Guide for cosmetic ingredients.
IASIS PHARMA, is a Greek Pharmaceutical Company active in the Production, R&D, Export and Trade of Pharmaceutical Products, Medical Devices and Cosmetics, with special focus on niche market therapeutic categories. IASIS PHARMA manufacturing facilities have been into operation since 1985. They have been renovated and upgraded twice according to Greek and EU Legislations, operating under the strictest GMP, GLP and GDP regulations. In 2012 the manufacturing plant has expanded with the addition of a new automatic production and packaging line for effervescent tablets. In 2016 IASIS PHARMA went ahead to acquire a new property in Attica where it now has under construction new Production Facilities, a Logistics & Distribution Center as well as a Research & Development Center. IASIS PHARMA is one of the major suppliers of the Greek Pharmaceutical market with high quality products, having a strong export operation, supplying EU, other European Countries, Middle East and North Africa with branded and/or private label medicinal and OTC products.
IBI Istituto Biochimico Italiano G. Lorenzini S.p.A. is an independent Italian research-based pharmaceutical company pioneer since 1918 in the development, production and marketing of medicines worldwide. Following our mission of “creating to contribute”, we have used innovative technology to develop a portfolio of products to improve the health of patients. IBI is present has an established leadership in penicillin market and capability of aseptic filling for injectable drug products aimed for different therapeutic areas. IBI's high quality standards is internationally recognized by the most demanding health authorities : AIFA, US FDA, EDQM, TGA and PMDA. R&D is one of the strengths of the Istituto Biochimico Italiano. Thanks to the fact that many manufacturing processes have been developed entirely in house; from the semi synthesis of active substances (ß-lactam) to the development of the formulations, the company has obtained numerous patents. Investment in resources and in innovative equipment enables us to continuously improve production and analytical processes.
IBSS BIOMED S.A. has been involved in the development, production and distribution of innovative, high quality pharmaceuticals and parapharmaceuticals since 1945. Currently it produces vaccines, probiotics and its metabolites, ORS to protect against: tetanus, diphtheria, urogenital tract infections, atopic dermatitis, sepsis in infants, dehydration, others. Certificates: cGMP, ISO 22000, ISO 13485.
ICB Pharma is a Polish
research-oriented company with over 25 years of experience in the fields of
health care, sanitary hygiene and crop protection. Our patented products
and solutions are present around the world. We are present in the following fields:
• Medical devices • Professional pest control • Agrochemicals for rural market • Home & garden Retail market
We offer specialty products in the area of the head lice treatment, prevention of the allergy and the tick-borne diseases such a Lyme disease and others.
We are looking for partners which see potential in distribution of unique medical devices based on many innovative technologies including for example encapsulation technology which allows to obtain the safest and the most efficient solution for the end users.
To ensure that ICB Pharma maintains its reputation as a leader in quality and effective products we have our own research and development laboratory along with the modern manufacturing facility.
ICF has been founded in 2002 and it has been the first Brazilian bioequivalence and bioavailability laboratory to get certified by ANVISA (Brazil). It is one of the largest pharmaceutical research centers in Brazil and in Latin America and a notable reference for industries and investors from several countries. ICF's commitment with ethics and innovation assure the credibility and quality of our products.
ICF has already conducted over 700 bioequivalence studies and it takes part in the history of generic drugs in Brazil. We offer one of the biggest hospital infrastructures in the country with a high technology, diversified portfolio and certificate, two hundred bioanalytical methods – including high complexity methods such as hormones and sprays.?
Being part of Israel Chemicals Ltd (ICL), the biggest producer of Bromine, ICL-IP Europe sells Bromine and Bromine- or Phosphor-based chemicals. In addition we offer custom and toll manufacturing services. Our products are used in the Flame Retardant and Life Science Industry. Having production facilities worldwide, we serve customers via a dedicated global network of sales and marketing offices.
ICL Specialty Minerals- produces a wide range of magnesium, Calcium and Potassium products at its facilities in Israel and France. All the products meet the most stringent Pharmacopoeia requirements and are produced in certified GMP facilities. For each compound, several grades are available, which are differentiated mainly by their physical properties, chemical reactivity and particle sizing.
Our main products are- Magnesium oxide, hydroxide and carbonate,Calcium carbonate, powder and directly Compressible (DC) range,
Refined KCL and Pure KCL.
ICON plc is a global provider of clinical development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development. With headquarters in Dublin, Ireland, ICON currently, operates from 84 locations in 38 countries and has approximately 12,300 employees. https://www.iconplc.com
ICROM is an Italian chemical-pharmaceutical Company specialized in
contract development and GMP manufacturing of Potent and non-Potent APIs. A
reliable partner with a strong know-how, that is present and active on the
worldwide pharmaceutical market since more than 40 years, and that with passion
and professionalism were able to diversify over the years its business model
and portfolio, strongly investing in research&development and innovative
products. With four state-of-the-art manufacturing units approved by AIFA, USFDA,
PMDA, KFDA and high-quality standards, ICROM is the partner of choice for
custom synthesis, contract manufacturing, niche generics, difficult-to-make
Ideal Cures Pvt Ltd is the world's leading manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. The product portfolio comprises INSTACOAT, INSTANUTE, ECOPOL range of Pharma Acrylic Polymer's, ECOCOOL brand of cooling compounds, ESPHERES range of sugar, MCC, SIO2 & Tartaric Acid spheres.
Idifarma is a leading Contract Development and Manufacturing Organization for the pharmaceutical and biotechnology industries. Based in Pamplona (Spain), and with an increasingly international reach, Idifarma provides a full range of services that encompasses: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, Pilot-Scale GMP-compliant manufacturing, ICH stability studies, clinical trial logistics management, regulatory support and commercial GMP manufacturing.
Our state-of-the-art facility features a purpose-built high containment plant for the manufacturing of GMP-compliant batches in oral solid dosage forms, for both conventional and high potency drugs. Our GLP certification allows us to develop products in any pharmaceutical dosage form as well as to carry out physical, chemical and microbiological analysis. Our GMP certification covers the following activities: manufacturing of pilot and commercial batches and as well as clinical batches in oral solid dosage forms (placebo, conventional drugs or high potency drugs), primary and secondary packaging for investigational drugs, importation of drugs and quality control and batch release (for human use drugs as well as investigational drugs).
We work with over 100 clients in more than 10 different countries (mainly in Europe) and during our 10 years
– Biopharmaceutical Contract Development & Manufacturing Services -
IDT operates one of Europe's premiere integrated biological and pharmaceutical development and manufacturing facilities. With decades of experience developing our own products as well as those of pharmaceutical industry third parties, we understand the needs of our customers when it comes to responsiveness, state-of-the-art technology and integrated solutions. The company focuses on three core areas – pharmaceuticals, vaccines and animal health.
IDT Biologika specializes in the development and manufacture of sterile liquid and lyophilized biopharmaceuticals and viral and bacterial vaccines, providing fully-integrated services ranging from formulation development and clinical manufacturing through to large-scale production, packaging and quality control.
Igb s.r.l. is a leading graphics and packaging company specialized in pharmaceutical folding cartons. Igb's patents include Tamper Evident and Child Resistant folding boxes that successfully address the needs of pharmaceutical companies worldwide. 100% quality control, ISO9001, ISO14000, OHSAS18,000, FSC, BC22301 certifications, GMP guidelines guarantee quality and sustainability.
The company IGS was formed in 1976 as the result of a MBO from Dynamit Nobel AG. In two manufacturing plants IGS currently produces over 2000 of its own formulations including products for human and veterinarian medicine. The company is certified according to ISO 9001, 14001, 13485 and VO (EEC) 1836/93. As a neutral contract aerosol filler IGS develops marketable formulations, improves existing recipes and prepares the entire galenic dossier for the manufacture and filling of aerosol-compatible preparations with or without propellant. The product range includes all pharmaceutical aerosols, filling of asthmatic dosage aerosols, notably Budesonid and Salbutamol MDIs, DPIs.
Who we are
As a medical company, you may have a great idea for a device that will give you a competitive edge.
But first you have to find a way to manufacture it according to the strict regulatory requirements for medical devices. IGS GeboJagema can help. For over 70 years, we have been delivering high precision moulds for some of the most successful metered dose inhalers, insulin pens, diagnostic products and other medical devices in the world.
Many of the key players in the medical industry bring their toughest product challenges to IGS GeboJagema. That's because we provide the solutions they need to help them innovate new products.
Our problem-solving mindset, proven track record in the healthcare industry, considerable medical experience and meticulously methodical way of working ensures you the highest quality, process control and traceability needed for your medical products.
We make moulds for products you still have to design
With the company`s slogan, 'Respect humanity', 'Promote human's health' and 'Improve welfare', Il-Yang Pharmaceutical Co. has tried its utmost to manufacture superior medicines for the last half a century. In addition, Il-Yang has put forth its strength for the construction of the country with healthy people under the banner of "challenging the limitations of the medical practice and pharmaceutical dispensing for one hundred years".
On the basis of the most advanced medical practice and pharmaceutical dispending and a solid business footing in the Korean market, Il-Yang has exported a variety of pharmaceuticals to approximately 30 countries in the world including the USA and Europe, and has opened an era of lacal production, by establishing Yangjoo Il-Yang Pharmaceutical Limited Company in China and manufacturing end-pharmaceuticals.
ILC Dover is a world leader in the innovative design and production of engineered products employing high-performance flexible materials. Since 1947, ILC has provided engineered solutions to complex customer problems. Known for the production of space suits for NASA, we leverage our vast materials, engineering and design experience to create high performance Powder Handling Systems for pharmaceutical and life sciences customers, Personal Protection Equipment and Lighter than Air systems for commercial and government customers, and Intermediate Bulk Packaging solutions www.graylingindustries.com for multiple industrial markets. With facilities in Delaware, Texas, Georgia, and Ireland ILC has over 450,000 square feet of office, development and manufacturing space. Behrman Capital is the majority shareholder of ILC Dover. ILC Dover
Founded in 1941, Ildong Pharmaceutical Co Ltd has been contributing to healthier and happier lives of mankind for more than 75 years. We've been developing innovative products by utilizing knowledge, know-how that we have piled up. We mainly manufacture Anticancer, Probiotics, Sodium Hyaluronate and Antibiotics in our state-of-the art facility. - API - FDF Pharmaceutical ;Oncology ;GI, Cardiovascular, Antivital Agents, Endo, CNS, Anti-histamine, Respiratory, NSAIDS and Urogenital ; Antibiotics(Quinolones, Cepholosporins) ; Fixed Dose Combination(Cardiovascular) - Probiotics(Raw material)- Food supplement- Sodium Hyaluronate(Raw material, Fermal Filler)
ILKO is a subsidiary of Selcuklu Holding which has strong institutions across various economic sectors.ILKO was founded by pharmacist Mustafa Öncel who was active in the pharmaceutical industry since 1973, resulting with successful sale of the previous pharma company to international partnerships, in 2006. Öncel family has invested again in pharmaceutical industry with their 40 years experience by young company, ILKO. The company has it's headquarter in ?stanbul, and R&D center in Hacettepe University, Ankara. ILKO has started its business activities in 2012. As of 2018, ILKO has over 600 employees with its own licensed 63 products within 147different forms in different therapeutic areas like; Central Nervous system, Respiratory System, Alimentary and Metabolism, Anti-infectives, Musco-Skeletal System, Cardiovascular System, Genitourinary System, Haematology, Endocrinology & Metabolism and Dermatologicals. ILKO has been approved for EU-GMP certificate by MHRA in the first quarter of 2014 and exports to more than 15 countries already. The production facility of the company is the largest pharmaceutical manufacturing investment in Anatolia. The production complex is located on a 250.000 m2 land and current closed area of the plant is 25.000 m2. The capacity of the plant has been planned for 120 million units per year covering production of different pharmaceutical forms. The current capacity of the first phase investment finalized in 2011 is 25 million units per year, on one shift. ILKO aims to offer innovative products that extend and save lives, as well as add value to the pharmaceutical industry. ILKO Research and Development Center located in Ankara Hacettepe University Technopark is a pioneer pharma research and development center within a University Organization in the country. ILKO R&D Biotechnology Center is located in Istanbul Technopark and has started its activies in 2015. Besides the value added conventional products, developing next generation biobetter and biosimilar products, novel biopharmaceuticals are in the main scope of the company. ILKOGEN is the biopharmaceutical company of ILKO. This joint venture company, ILKOGEN, has been established with one of the leading South Korean biotechnology research company Genexine Inc. in December 2013. A Biobetter product is being developed and Phase II studies are still on going. Business strategy of ILKO is being a global pharmaceutical company by expanding its activities with next generation R&D activities as well as by developing strong business co-operations in; import, export, in and out licensing, and Co-development. In 2016, ILKO has created the brand of Wellcare just about to give a different impulse to Healthcare area with its strong background in pharma industry on the basis of new and ever-changing demands of today, with the target of creating a global brand. Wellcare has products within 6 different categories including; Infant Health, Digestion, Probiotics, Allergy, Vitamins and Minerals, Cough and Cold. Wellcare targets to enhance life quality, provide solutions for health problems in each stage of lifecycle from birth with its innovative, clinical effectiveness' proven, scientific and trustable subsidiary treatment products approved by health authorities.
IMAP is a company dedicated to the production of Plastic Primary Packaging for the Pharmaceutical and Food Industries. Founded in 1940 by a German immigrant, it was one of the first companies in Argentina dedicated to thermoplastic transformation. It manufactures through injection, injection-blow molding and blow molding. It also offers value-added services such as decoration (offset, screen printing and labeling), set assembly, garrison placement, etc… Production is in clean room: positive air pressure (ISO 8 standard), epoxy floors, sanitary skirting boards, no cardboard in the area, external raw material supply. Main product lines:
- Tubes and caps for effervescent tablets (main producer in South America)
- PE and PET Standard medicinal bottles (RP28) with caps (TE and CR)
- PET Bottles (DIN18) with caps.
- Dosing syringes
- Droppers with scale
IMCD Pharmaceuticals is the number 1 distributor of speciality pharmaceutical ingredients in EMEA, Asia-Pacific and Americas. We supply the
most comprehensive range of excipients, active pharmaceutical ingredients and
speciality solvents, process chemicals and intermediates for chemical
synthesis. Our extensive network of pharmacists, chemists and experienced
formulators allows us to work closely with our clients operational and research
& development departments; delivering total product solutions for today's
most demanding of manufacturing environments. IMCD's partnership with the
worlds leading suppliers brings expertise, innovation and production efficiency
to the pharmaceutical, generic, OTC and nutraceutical companies across the
IMCD – Value through expertise.
IMCoPharma is a fully-serviced pharmaceutical company that researches, markets and distributes innovative, best-in-class products and services to its customers within CIS region. IMCoPharma creates a business alliance between the EU and CIS pharmaceutical markets, with the objective of deepening and expanding business activities and developing strong partnership. Based on many years of experience of operation, targeting and knowledge of the local pharmaceutical markets, the company gained the status of a strong and responsible partner for CIS countries.
IMS, founded in 1973, is an outsource company leader in the pharmaceutical powders micronization. We are AIFA-authorized, FDA-approved, with a Japan accreditation for foreign manufacturer and ISO 9001:2008 certified. Located in Milan, Italy, it covers an area of 1820m2 with nine clean rooms of which two are steroids-dedicated and segregated. A sophisticated HVAC system regulates the temperature, humidity and over-pressures inside the production department. Each box has its own SAS to avoid contamination, and an independent conditioning system. In the CQ laboratory the particle size
specifications are guaranteed by laser
technology analysis .
Ind-Swift Group constitutes 3 companies, Ind-Swift laboratories Ltd (US-FDA Approved Manufacturer of APIs), Ind-Swift Ltd (Manufacturer of Finished Dosage Forms) & Ind-Swift Inc (US Subsidiary). With manufacturing sites at 7 different locations across India and an independent State-of-the-Art R&D Centre, the Group has established itself as a reliable partner in the Global Pharmaceutical Industry. In-House capabilities for Development of APIs, Finished Dosage Forms, Non-Infringing Processes, Contract Manufacturing (Finished Dosages/APIs) are the in-valuable strengths. The Company has certifications from International Bodies such as US-FDA, TGA Australia and EDQM.
We have over 25 years' experience in the manufacture of rigid plastic packaging for pharmaceutical industry. Operating under the ISO 9001 and 15378 (GMP's) certifications we boast 2 production plants with over 8500 m2 which are located in Spain, including 5 Clean Rooms with the latest equipment and technology. We produce over 200 million plastic packages a year in PET, PE and PP materials such as pill jars and bottles for solid and liquid dosage forms, bottles for nasal spray and other.
Indena is an Italian company specialised in the isolation,
development and bulk-manufacturing of active pharmaceutical ingredients from
In more than 90 years Indena has established sales in over 70 countries, complying with the highest quality standards and the most strict regulations.
Significant company resources are invested in developing innovative and environmentally benign processes.
Indena, very well known as the leading supplier of natural/semisynthetic APIs, HPAIs and high quality extracts, particularly in the high potency APIs, not limited to phytopharmaceuticals, today supplies also capacity and expertise for custom manufacturing services and related key technologies to multinational companies.- www.indena.com
India Glycols Limited (Ennature) manufactures Thiocolchicoside, Colchicine, Vinpocetine, Nicotine (Nictobac) Centella Asiatica, Ethanol extracted & water soluble Curcumin (Maxicuma) We offer array of carotenoids Lutein, Lutein ester CO2 extract ,Astaxanthin, Zeaxanthin and Health supplements: Solvent free Ginger, Coleus, Policosanol, Boswellia Serrata Extract, Sea-buckthorn oil, Algal-Vegetarian DHA, Pumpkin-seed Oil. Seeking Distributors form global markets.
Indis nv is a family owned company located in Belgium, serving the Pharma industry worldwide as your reliable partner for over 30 years. We can help you with your new and existing projects, finding for you in full transparancy the best possible sources and giving you regulatory and logistic support. INDIS nv is a distribution company for pharmaceutical raw materials and excipients to the pharmaceutical industry, both human and veterinary, and for products to the health-food industry. We are a small but flexible company and we have a good impact on the pharmaceutical market as we have been in this business for more than 30 years. We support our clients not only commercially, but also by finding them new sources, assisting them with regulatory matters, technical issues, getting the right documentation, organising factory audits, etc
We are the leading manufacturer Exporter of Fine Chemicals, Specialty and Performance chemicals in India.
Our products have applications in a wide range of industries including Textiles,Pharmaceuticals, Agrochemicals, Fertilizers, Petrochemicals, Pesticides, Perfumery Chemicals, Dyes and Intermediates etc.
We are an ISO 9001 Certified Company having factories at various locations in India and exporting to 50 Countries worldwide.
We INDO PHYTOCHEM GROUP (INDO PHYTOCHEM
PHARMACEUTICALS & INDO HERBAL EXTRACTIONS) a leading
manufacturer of Calcium Sennosides, most potent Phytochemicals – used as API,
Standardized Herbal Extracts and Nutraceutical Ingredients as per International
valid Pharmacopoeia standards. We are the fairly biggest manufacturer of
Yohimbine HCL 98% ; Rauwolscine HCL 90%-98% &
Cassia Angustifolia (Senna) Extract – Sennoside 10% - 98%, Calcium Sennosides
10%-98% in INDIA. We are exporting
worldwide and supplying to many Indian Exporter and manufacturer.
We stand for Quality, Competitiveness, Innovation, Trust & Transparency. Our
group companies are accredited with ISO 9001:2008, ISO 22000:2005, State-GMP,
WHO-GMP, STAR K-KOSHER.
Indoco Remedies Limited, headquartered in India, is a fast growing, fully integrated, research based, pharmaceutical company with global presence. We produce a wide range of quality, affordable products in various therapeutic segments that are well accepted by health care professionals and customers worldwide. The company has a strong manufacturing setup, a focus on Research & Development and is uniquely positioned as a preferred partner offering complete solutions to pharmaceutical companies marketing generics. Our offer includes Contract Research and Custom Synthesis, APIs & Formulation Development, Regulatory support and Manufacturing services for APIs, Intermediates of APIs and Finished Dosage forms.
Indukern Chemie AG is part of Indukern Group and one of the world's leading suppliers of raw materials for the veterinary, pharmaceutical, nutraceutical, food and feed industry.
Since 1986 we are your global partner for supply chain management, cost efficiency and sourcing. Our aim is to keep our customers and partners ahead competition and serve their needs of innovation with in-time service and personal engagement.
With more than 20 sales offices, subsidiaries and group related sales offices all over the world – Indukern is able to take care about your supply chain globally.
Grupo Indukern a national and international benchmark in chemical distribution and in the development, manufacture and marketing of pharmaceutical and veterinary products.
The Group began operations in 1962 and has developed as a global corporate group thanks to growth based both on the strategic creation of subsidiaries and local partners, and expansion into different product lines:
Indukern S.A. and Subsidiaries :
With its five business divisions, Indukern is a leading specialist firm in chemicals distribution and higher value-added activities of formulation, production and technical advice for various industry sectors.
Animal nutrition and Feed Flavour and Fragrance Ingredients Food Ingredients Industrial Chemicals Pharmaceutical Ingredients
Laboratorios Calier, S.A. and Subsidiaries:
Committed to animal health and welfare, Calier is a research, development and marketing company of pharmacological and biological products for:
KERN PHARMA, S.L.
The activity of Kern Pharma is based on two strategic core areas of business:
Development, manufacture and marketing of pharmaceutical products, with emphasis on generics and ethicals. It also markets products for the OTC market, biosimilars, women's health (Gynea), health and sports nutrition (Finisher). Comprehensive process of product development, contract manufacturing and chemical production for third parties.
VIR is a private pharmaceutical company founded in 1939. The aim of the Laboratory has been, from its origins, to develop, manufacture and market pharmaceutical specialities. VIR has a subsidiary in Portugal. Nowadays VIR is in top 10 of the Spanish Pharmaceutical companies according to IMS data.
We, Infinium Pharmachem Pvt Ltd (GMP Compliant ,FDA,ISO-9001 and ISO-14001 certified Manufacturing Co.), incorporated in the year 2003, with manufacturing facilities at Gujarat, India .
Our products have various applications in pharmaceutical, electronics chemical, Solar Cell, foods etc. We are working as CRAMS for manufacturing of various Organic and Inorganic Iodine derivatives. We can provide full A-Z vendor documents support to meet your stringent regulatory compliance requirement to file documents with various authorities for Pharma companies. We have audit able manufacturing facility and it have been audited by various well known pharma giants worldwide.
You are always welcome with demand of any new iodine based compounds or other products. We can develop and supply the same specifically / strictly as per your requirement and application. We are even ready to sign Non Disclosure Agreement (NDA) for development of rarely available compound.
INFRA is a leader in the manufacturing of flexible bags for sterile solutions and medical devices for pharmaceutical applications as nutrition, preparation and administration of antiblastic drugs. INFRA is certified UNI EN ISO 9001:2015 and UNI EN ISO 13485:2016.With over 40th years of experience INFRA is able to offer the most suitable solution of primary packaging for pharmaceutical and medical field.
Good ingredients make good medicine!
INIST ST was founded as DONGWOO SYNTECH CO., LTD. in 2000
and ?has been a leader in medical supply ingredients and ingredient
?synthesizing technology development.
Based on change, innovation and affection for life, INIST ST started
the development of cerebrovascular medicine and has continued
by researching and developing excellent quality generic ingredients
and base change incrementally modified drugs and is supplying them
locally and globally.
Based on long-standing trust and skill, we develop not only multiple
first generic ingredients, but also innovative new drugs such as heart
disease contrast medium and a calcium blockade anti-cancer drug, and
now our advanced technology surpasses the high barriers of the global
market, and we are leading as a pioneer in the global market, such as
exporting more than 15 billion KRW of products to Japan, a medically
Inke, based in Barcelona, part of the NuPharm Group, has been producing high quality APIs since 1980. Inke has been successfully inspected by every major global authority for a wide array of products. For the last two decades, we have made strong strides to become a prestige provider of respiratory APIs for inhalation.
KEB is a professional manufactory to supply standardized plant extracts, functional sugars, natural pigments for supplyments, pharmaceuticals, nutraceuticals, cosmetic etc. Currently, KEB Corporation includes Kailu Ever Brilliance Biotechnology Co., Ltd (KEB Bio), Inner Mongolia Sci-Geely Biotechnology Co., Ltd (Sci-Geely Bio), Beijing Simplex Tech & Trade Co., Ltd (Simplex), Chenze Instituted of Bio-fermentation (CIB) and KEB Nutraceutical USA, Inc (KEB Nutra).
KEB is a China's high-tech enterprise, and has a post-doctoral research center, a key industrial lab of Inner Mongolia, and an Academician workstation. KEB has closely cooperated with Beijing University of Chemical Technology (BUCT), Institute of Process Engineering CAS, University of Science and Technology Beijing (USTB), Peking University (PKU), which enable KEB to assemble a team of professionals including technical expertise,sales, and customer service supported by a team of top scientists and biochemists assembled globally.
KEB set up a quality management system and got many certifications, such as ISO9001, ISO22000, FAMI-QS, Non GMO and Kosher. Our ideas is “Condensed Nature for Health”. We will always supply the excellent products for our customers
Inner Mongolia Glint Medicine Co Lt., is a leading manufacturer of pharmaceuticals as well as a big scale drugs whole sale company approved by Inner Mongolian FDA. From the beginning of coming into being, she devotes herself in development of domestic and overseas markets. Meanwhile, she realized great progress through horizontal and vertical cooperation with big enterprises in China in way of joint share or holding share. Nowadays, she has been building up a wide and stable sales network in national and international markets.
Innophos partners with clients, creating essential ingredients to improve quality of life. We are an international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. Innophos has manufacturing operations across the US, in Canada, Mexico and China.
InnoSyn offers a team of passionate & experienced problem solvers, applying innovative and cost-efficient technologies such as flow chemistry, bio- and chemo-catalysis. If you need a scalable route for your new chemical compound (INVENT), or a better yield of your current product (IMPROVE), or manufacturing capacity for your product (IMPLEMENT), InnoSyn can help.
- Unit-I (G-Block): Incorporated in 2006
- Unit-II (C-Block): Incorporated in 2010
- Unit –III (G-Block): Incorporated in 2017
Inpharmatis is a company with a CRO business model and which today is the sole provider of full scale pharmacovigilance services with full CIS country coverage and EU quality. The company is the only one in the Baltic states with an eSolutions department, offering full digitalisation of pharmaceutical companies for eCTD, various areas of pharmacovigilance, as well as quality departments (GMP).
INSIGHT Health is a leading distributor of pharmaceutical information in Germany, currently expanding worldwide. Essential data, comprehensive knowledge and expertise are our contributions to your success in the health care market. Gathering and evaluating information from various data sources, such as pharmaceutical wholesalers, pharmacy coding centers and pharmacy panel data, provide the basis for solid data analyses. SHARK - our comprehensive patent database - is a must-have tool for business development guiding you to safe future planning. Bypass the patent cliff, or be the shark in future generics - it is your decision!
IHT Group consists of IHT (Beijing), IHT(Tianjin) and IHT (Jiangsu), and is the leading manufacturer of photoinitiators, pharmaceutical intermediates and fine chemicals manufacturer with the ability of successively technology innovation and scale-up production.
It is the leading enterprise in the UV curing industry of China and the main supplier of middle and high-end photoinitiators for global UV curing market with partners all over the world.
Over the past 20 years Institut Allergosan has created a center-of-excellence in microbiota research and has developed outstanding products in the area of gut health. Its successful portfolio of medical relevant probiotics comprises of 9 products for different indications and special orthomolecular products for intestinal health – ready to be licensed-out.
Intas Pharmaceuticals, Ltd. is a global independent generic pharmaceutical company headquartered in India. With strong R&D and manufacturing capabilities and many years of experience in highly regulated markets, Intas delivered sales of USD 1.4 bM in 2017/18.Intas is an important 3rd Party licensor and is proud to supply more than 100 different finished products to more than 80 pharmaceutical companies in EMEA, APAC, CANADA and LATAM. For its EU based customers, batch testing & release services are provided from its Barcelona lab. Intas currently operates 4 GMP sites in India, 2 in UK and 1 in Mexico, capable of doing tabs, caps, effervescent tabs, ointments for high potent drugs, onco orals and onco injectables, including pre-filled syringes.Intas is vertically integrated into APIs for some of its key products. Intas is also developing added value or difficult-to-make products in respiratory, women healthcare, dermatology, pain, CNS and CV with EU based CDMOs. Intas' biotech division runs an EMA GMP certified biopharmaceutical site in Ahmedabad for the production of recombinant proteins (cell culture or fermentation). Intas is proud to be the 1st Indian company to have registered and commercially marketed a biosimilar (“Accofil” brand for GCSF) and the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion in Europe for Pelgraz®, our version of pegylated Granulocyte-Colony Stimulating Factor (G-CSF). This will be the second in-house developed biosimilar launched in Europe.
We are a young and dynamic organization, specializing in modular cleanrooms, cleanroom products, lab furniture and turnkey solutions. Through our registered office located at Hyderabad, India, we offer complete sales and service support to our customers. Our turnkey solutions include design, manufacture, installation and validation of complete modular cleanrooms along with seamlessly integrated HVAC systems. We have to our credit some of the most intricate and demanding jobs under class of cleanliness ranging from Class-100,000 to Class-100 for pharma, biotech, electronics, healthcare and general industry.
IntelGenx is a Leader in Pharmaceutical Film Development & Manufacturing. Our mission is to Make Approved Drugs Better, with next generation pharmaceutical products that address unmet medical needs, and offer significant benefits to patients and physicians. Our film proprietary technologies, VersaFilm™ and VetaFilm™, enable the development of pharmaceutical oral films with potential to improve absorption, accelerate onset of action, reduce side effects, ease administration and improve patient compliance. IntelGenx' highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, intellectual property, regulatory and manufacturing services. We Offer: • Development and Manufacturing by Contract and • Licensing-Out of Innovative Oral Film Products. Our teams of experts are committed to go above and beyond to satisfy the needs of our partners.
For over 20 years, Interchem has been successfully locating sources of basic fine chemicals, intermediates, APIs and next generation sophisticated compounds. Interchem has earned its reputation by serving as the marketing, technical, and regulatory liaison between customers and producers, including ACS Dobfar, Fermion and Stragen; using effective project management skills and techniques. With the expansive range of chemistries at its disposal, you need look no further when considering where to source a new compound or outsource an existing product. The technical team will assist with regulatory interpretations, compiling of documentation, conducting audits, and assisting with technical transfers and chemical development.
The company "InterChem" was founded in 1992 on the basis of the pilot plant of A.V. Bogatskiy Physico-Chemical Institute of the Academy of Sciences of Ukraine, and in 2012 celebrated its 20th anniversary. Commercial activity started with the production of the unique products of fine organic synthesis, then the production of original active pharmaceutical ingredients was launched, these API's were developed by the scientists of A.V. Bogatsky Physico-Chemical Institute. We also dealt with the import of the substitution substances that have never been produced in Ukraine before. The key event in the development of our company was the creation of the plant for the production of drugs. Building started in August 2002 with "zero cycle" according to the European rules - Good Manufacturing Practices (GMP). We have realized this project from the first pile to starting production during the record period of time - 2 years. This event was the closing link in the creation of the domestic pharmaceutical industry of the full cycle, performing screening and the development of active chemical compounds - the production of API's - manufacture of drugs - wholesale and retail sale of the drugs by the same company. As soon as four years after the start of production the second production line was put into operation, which allowed to increase the volume of production by 4 times. Since 2007, the production line of ready-made medicines is being regularly certified for compliance with international standards of good manufacturing practice (GMP).